SSI Investment Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$11.1M Sell
2022
Q4
$10.6M Buy
2022
Q3
$7.75M Sell
2022
Q2
$10.5M Sell
2022
Q1
$12M Buy
2021
Q4
$11.7M Buy